Durable Response to Nivolumab in a Patient With Hepatic Sarcomatoid Carcinoma: Evolutive Characterization of Genomic and Immunohistochemical PD-L1 Expression Findings

Detalles Bibliográficos
Autores principales: Queiroz, Marcello M., Munhoz, Rodrigo R., Masotti, Cibele, Souza, Larissa M., Lima, Luiz G.C.A., Asprino, Paula F., Begnami, Maria Dirlei F.S., Camargo, Anamaria A., Bettoni, Fabiana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489170/
https://www.ncbi.nlm.nih.gov/pubmed/36044716
http://dx.doi.org/10.1200/PO.22.00163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489170/
https://www.ncbi.nlm.nih.gov/pubmed/36044716
http://dx.doi.org/10.1200/PO.22.00163

Ejemplares similares